Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and the general public to listen to a live audio webcast of its 2012 Investor Meeting on Tuesday, December 11, 2012 at 12:00 p.m. ET.
|Teva’s 2012 Investor Meeting|
|Tuesday, December 11, 2012 at 12:00 p.m. ET|
|Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.|
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011.